Institute of Biomedical Sciences/Unit of Xerem, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
J Leukoc Biol. 2018 Jul;104(1):49-60. doi: 10.1002/JLB.4MR1117-473R. Epub 2018 Mar 9.
Eosinophils are the prominent cells in asthma, allergic bronchopulmonary mycosis (ABPMs), and fungal-sensitization-associated asthma, but their roles in the immunopathology of these disorders are not well understood. Moreover, the immunological mechanisms underlying the molecular direct effector interactions between fungi and eosinophils are rare and not fully known. Here, we provide an overview of eosinophil contributions to allergic asthma and ABPMs. We also revise the major general mechanisms of fungal recognition by eosinophils and consider past and recent advances in our understanding of the molecular mechanisms associated with eosinophil innate effector responses to different fungal species relevant to ABPMs (Alternaria alternata, Candida albicans, and Aspergillus fumigatus). We further examine and speculate about the therapeutic relevance of these findings in fungus-associated allergic pulmonary diseases.
嗜酸性粒细胞是哮喘、变应性支气管肺曲霉病(ABPMs)和真菌致敏相关哮喘的主要细胞,但它们在这些疾病的免疫病理学中的作用尚不清楚。此外,真菌与嗜酸性粒细胞之间分子直接效应子相互作用的免疫机制很少且尚未完全了解。在这里,我们概述了嗜酸性粒细胞对过敏性哮喘和 ABPMs 的贡献。我们还修正了嗜酸性粒细胞识别真菌的主要一般机制,并考虑了我们对与 ABPMs 相关的不同真菌物种(链格孢、白念珠菌和烟曲霉)相关的嗜酸性粒细胞先天效应子反应的分子机制的理解的过去和最新进展。我们进一步研究和推测这些发现与真菌相关的过敏性肺部疾病的治疗相关性。